Clinical and Ultrasonographic Assessment of Nail Psoriasis: A Comprehensive Study
Introduction: In patients with plaque type psoriasis (PSO), the progression to psoriatic arthritis (PsA) exacerbates the disease's impact and increases disability risk. Nail psoriasis (NP) affects up to 90% of PSO patients with a wide spectrum of clinical features and is a significant predicto...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mattioli1885
2025-07-01
|
| Series: | Dermatology Practical & Conceptual |
| Subjects: | |
| Online Access: | https://dpcj.org/index.php/dpc/article/view/5318 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849739192029937664 |
|---|---|
| author | Maria Esposito Lina Maria Magnanimi Paolo Antonetti Andrea De Berardinis Cristina Pellegrini Emanuele Vagnozzi Manfredo Bruni Camilla Gianneramo Paola Cipriani Maria Concetta Fargnoli Antonio Barile Piero Ruscitti |
| author_facet | Maria Esposito Lina Maria Magnanimi Paolo Antonetti Andrea De Berardinis Cristina Pellegrini Emanuele Vagnozzi Manfredo Bruni Camilla Gianneramo Paola Cipriani Maria Concetta Fargnoli Antonio Barile Piero Ruscitti |
| author_sort | Maria Esposito |
| collection | DOAJ |
| description |
Introduction: In patients with plaque type psoriasis (PSO), the progression to psoriatic arthritis (PsA) exacerbates the disease's impact and increases disability risk. Nail psoriasis (NP) affects up to 90% of PSO patients with a wide spectrum of clinical features and is a significant predictor of enthesitis, often associated with early PsA stages.
Objective: This study aimed to clinically and ultrasonographically evaluate nail units in PSO patients, focusing on differences between those with/without PsA and those with/without onychopathy.
Methods: Sixty patients were enrolled (23/60 PSO-37/60 PSO and PsA). PSO and PsA patients were evaluated and compared as well as patients with/without diagnosis of nail psoriasis in this cross-sectional single-center study. Nail abnormalities were evaluated by high frequency ultrasound (HFUS) using high frequency probes (27 MHz). After a descriptive assessment, the Nail Psoriasis Severity Index (NAPSI) and the Brown University Nail Enthesis Scale (BUNES) were used to clinically and ultrasonographically assess nails.
Results: HFUS evaluation identified a spectrum of nail and blood flow alterations. Nail disease was characterized by median NAPSI 16 (range 28), median BUNES morphometry 1.5 (range 0.9), and median BUNES power Doppler (PD) 2.2 (range 4.03). Among the studied sample, 43/60 (71.7%) presented nail psoriasis, with 69.7% presenting coexisting PsA as compared to PSO patients (30.3%) (p = 0.04).
Conclusion: Our findings highlight the importance of close collaboration between dermatologists and rheumatologists in the evaluation of PSO patients, taking advantage of both clinical and ultrasonographic assessment of nail damage.
|
| format | Article |
| id | doaj-art-23627600d11b4e7fa732c638fbc7ad2a |
| institution | DOAJ |
| issn | 2160-9381 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Mattioli1885 |
| record_format | Article |
| series | Dermatology Practical & Conceptual |
| spelling | doaj-art-23627600d11b4e7fa732c638fbc7ad2a2025-08-20T03:06:20ZengMattioli1885Dermatology Practical & Conceptual2160-93812025-07-0115310.5826/dpc.1503a5318Clinical and Ultrasonographic Assessment of Nail Psoriasis: A Comprehensive StudyMaria Esposito0Lina Maria Magnanimi1https://orcid.org/0000-0003-2056-9483Paolo Antonetti2Andrea De Berardinis3Cristina Pellegrini4Emanuele Vagnozzi5Manfredo Bruni6https://orcid.org/0000-0001-9357-9653Camilla Gianneramo7Paola Cipriani8Maria Concetta Fargnoli9Antonio Barile10Piero Ruscitti11Biotechnological and Applied Clinical Sciences - University of L'AquilaDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyDermatology Unit, San Salvatore Hospital, L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyDepartment of Emergency and Interventional Radiology, San Salvatore Hospital, L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy Introduction: In patients with plaque type psoriasis (PSO), the progression to psoriatic arthritis (PsA) exacerbates the disease's impact and increases disability risk. Nail psoriasis (NP) affects up to 90% of PSO patients with a wide spectrum of clinical features and is a significant predictor of enthesitis, often associated with early PsA stages. Objective: This study aimed to clinically and ultrasonographically evaluate nail units in PSO patients, focusing on differences between those with/without PsA and those with/without onychopathy. Methods: Sixty patients were enrolled (23/60 PSO-37/60 PSO and PsA). PSO and PsA patients were evaluated and compared as well as patients with/without diagnosis of nail psoriasis in this cross-sectional single-center study. Nail abnormalities were evaluated by high frequency ultrasound (HFUS) using high frequency probes (27 MHz). After a descriptive assessment, the Nail Psoriasis Severity Index (NAPSI) and the Brown University Nail Enthesis Scale (BUNES) were used to clinically and ultrasonographically assess nails. Results: HFUS evaluation identified a spectrum of nail and blood flow alterations. Nail disease was characterized by median NAPSI 16 (range 28), median BUNES morphometry 1.5 (range 0.9), and median BUNES power Doppler (PD) 2.2 (range 4.03). Among the studied sample, 43/60 (71.7%) presented nail psoriasis, with 69.7% presenting coexisting PsA as compared to PSO patients (30.3%) (p = 0.04). Conclusion: Our findings highlight the importance of close collaboration between dermatologists and rheumatologists in the evaluation of PSO patients, taking advantage of both clinical and ultrasonographic assessment of nail damage. https://dpcj.org/index.php/dpc/article/view/5318nail psoriasis High Frequency UltrasoundPsoriatic ArthritisPsoriasis Diagnosis |
| spellingShingle | Maria Esposito Lina Maria Magnanimi Paolo Antonetti Andrea De Berardinis Cristina Pellegrini Emanuele Vagnozzi Manfredo Bruni Camilla Gianneramo Paola Cipriani Maria Concetta Fargnoli Antonio Barile Piero Ruscitti Clinical and Ultrasonographic Assessment of Nail Psoriasis: A Comprehensive Study Dermatology Practical & Conceptual nail psoriasis High Frequency Ultrasound Psoriatic Arthritis Psoriasis Diagnosis |
| title | Clinical and Ultrasonographic Assessment of Nail Psoriasis: A Comprehensive Study |
| title_full | Clinical and Ultrasonographic Assessment of Nail Psoriasis: A Comprehensive Study |
| title_fullStr | Clinical and Ultrasonographic Assessment of Nail Psoriasis: A Comprehensive Study |
| title_full_unstemmed | Clinical and Ultrasonographic Assessment of Nail Psoriasis: A Comprehensive Study |
| title_short | Clinical and Ultrasonographic Assessment of Nail Psoriasis: A Comprehensive Study |
| title_sort | clinical and ultrasonographic assessment of nail psoriasis a comprehensive study |
| topic | nail psoriasis High Frequency Ultrasound Psoriatic Arthritis Psoriasis Diagnosis |
| url | https://dpcj.org/index.php/dpc/article/view/5318 |
| work_keys_str_mv | AT mariaesposito clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy AT linamariamagnanimi clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy AT paoloantonetti clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy AT andreadeberardinis clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy AT cristinapellegrini clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy AT emanuelevagnozzi clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy AT manfredobruni clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy AT camillagianneramo clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy AT paolacipriani clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy AT mariaconcettafargnoli clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy AT antoniobarile clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy AT pieroruscitti clinicalandultrasonographicassessmentofnailpsoriasisacomprehensivestudy |